David Lucchino's Circuitous Route To CEO Of Frequency Therapeutics
Source: Life Science Leader
By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
What do baseball, broadcast journalism, and biotech have in common? All are part of the life and unconventional career journey of David Lucchino, cofounder and CEO of Frequency Therapeutics (NASDAQ: FREQ). It’s a path that bucks conventional wisdom, much like what Frequency is trying to do with its goal to restore hearing loss — something previously considered impossible.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more